Purification of adenovirus and adeno-associated virus: Comparison of novel membrane-based technology to conventional techniques

Gene Therapy

Volumn 12, Issue , 2005, Pages S62-S72

  Duffy, A M ^a   O'Doherty, A M ^a   O'Brien, T ^a   Strappe, P M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Adeno associated virus; Adenovirus; Ion exchange; Purification

Indexed keywords

ADENOVIRUS VECTOR; PARVOVIRUS VECTOR;

AFFINITY CHROMATOGRAPHY; ANALYTICAL EQUIPMENT; BIOTECHNOLOGY; CELL STRAIN HEK293; CONFERENCE PAPER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION; WILD TYPE;

ADENOVIRIDAE; BIOTECHNOLOGY; CELL LINE; DEPENDOVIRUS; FREE RADICAL SCAVENGERS; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; RECOMBINANT FUSION PROTEINS; STAINING AND LABELING; SUPEROXIDE DISMUTASE; TRANSGENES; VIROLOGY;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; PARVOVIRUS;

EID: 27544491928     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302616     Document Type: Article

References (28)

1. Hacein-Bey-Abina S et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
2. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999; 401: 517-518.
3. Huyghe BG et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther 1995; 6: 1403-1416.
4. Blanche F et al. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Therapy 2000; 7: 1055-1062.
5. Shabram PW et al. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 1997; 8: 453-465.
6. Klyushnichenko V, Bernier A, Kamen A, Harmsen E. Improved high-performance liquid chromatographic method in the analysis of adenoviral particles. J Chromatogr B Biomed Sci Appl 2001; 755: 27-36.
7. Vellekamp G et al. Empty capsids in column-purified recombinant adenovirus preparations. Hum Gene Ther 2001; 12: 1923-1936.
8. Adenopure Instruction Manual www.puresyn.com.
9. Graham FL, Smiley J, Russel WC, Narin R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1997; 36: 59-72.
10. Zhang WW, Koch PE, Roth JA. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 1995; 18: 444-447.
11. Clark KR, Liu X, McGrath JP, Johnson PR. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild type viruses. Hum Gene Ther 1999; 10: 1031-1039.
12. Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973-985.
13. Auricchio A et al. Isolation of highly infectious and pure adeno- associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 2001; 12: 71-76.
14. Brument N et al. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol Ther 2002; 6: 678-686.
15. www.virapur.com.
16. Green AP et al. A new scalable method for the purification of recombinant adenovirus vectors. Hum Gene Ther 2002; 13: 1921-1934.
17. McIntyre, 2001-Adenovirus Reference Material Working Group is a consortium of industry, government and academic researchers to manufacture adenovirus reference standards and codify analytical methods under the auspices of the FDA. Information is available at www.wilbio.com.
18. Zhu J et al. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum Gene Ther 1999; 10: 113-121.
19. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
20. Gao G et al. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum Gene Ther 2000; 11: 2079-2091.
21. Smith RH, Ding C, Kotin RM. Serum-free production and column purification of adeno-associated virus type 5. J Virol Methods 2003; 114: 115-124.
22. Grimm D, Kern A, Rittner K, Kleinschmidt JA. Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 1998; 9: 2745-2760.
23. Rabinowitz JE et al. Cross-dressing the virion: the transcapsida- tion of adeno-associated virus serotypes functionally defines subgroups. J Virol 2004; 78: 4421-4432.
24. Kaludov N et al. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity J Virol 2001; 75: 6884-6893.
25. Walters RW et al. Binding of adeno-associated virus type 5 to 2, 3-linked sialic acid is required for gene transfer. J Biol Chem 2001; 276: 20610-20616.
26. Davidoff AM et al. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J Virol Methods 2004; 121: 209-215.
27. Harris JD, Beattie SG, Dickson JG. Novel tools for production and purification of recombinant adeno-associated viral vectors. Methods Mol Med 2003; 76: 255-267.
28. Maizel Jr JV, White DO, Scharff MD. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 1968; 36:126-136.